Publications by authors named "Tony Cohn"

Claim this Profile
P
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Sri Mahavir Agarwal, Nicolette Stogios, Zohra A Ahsan, Jonathan T Lockwood, Markus J Duncan, Tony Cohn

Cochrane Database Syst Rev· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining strategies to improve accelerometer compliance for individuals living with schizophrenia.
Paul Gorczynski, Guy Faulkner, Tony Cohn, Gary Remington

Psychiatr Rehabil J· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal model.
Margaret K Hahn, Araba Chintoh, Gary Remington, Celine Teo, Steve Mann, Tony Cohn

Eur Neuropsychopharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute effects of single-dose olanzapine on metabolic, endocrine, and inflammatory markers in healthy controls.
Margaret Karolina Hahn, Tom M S Wolever, Tamara Arenovich, Celine Teo, Adria Giacca, Tony Cohn

J Clin Psychopharmacol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of point-of-choice prompts on stair usage in a psychiatric setting.
Paul F Gorczynski, Guy E Faulkner, Tony A Cohn, Gary J Remington

Psychiatr Serv· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical antipsychotics and diabetic ketoacidosis: a review.
Melanie D Guenette, Margaret Hahn, Tony A Cohn, Celine Teo, Gary J Remington

Psychopharmacology (Berl)· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters.
Margaret K Hahn, Tony Cohn, Celine Teo, Gary Remington

Clin Schizophr Relat Psychoses· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model.
Margaret Hahn, Araba Chintoh, Adria Giacca, Li Xu, Loretta Lam, Tony Cohn

Schizophr Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking cessation in women with severe mental illness: exploring the role of exercise as an adjunct treatment.
Kelly P Arbour-Nicitopoulos, Guy E Faulkner, Tony A Cohn, Peter Selby

Arch Psychiatr Nurs· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effects.
Margaret K Hahn, Gary Remington, Daniel Bois, Tony Cohn

J Clin Psychopharmacol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
Anitha Mukundan, Guy Faulkner, Tony Cohn, Gary Remington

Cochrane Database Syst Rev· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment: Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
Margaret K Hahn, Tony Cohn, Gary Remington

Ann Pharmacother· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the construct validity of the transtheoretical model to structure physical activity interventions for individuals with serious mental illness.
Paul Gorczynski, Guy Faulkner, Steven Greening, Tony Cohn

Psychiatr Rehabil J· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Schizophrenia and obesity: addressing obesogenic environments in mental health settings.
Tony Cohn, Shannan Grant, Guy E Faulkner

Schizophr Res· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body image in individuals with schizophrenia: examination of the B-WISE questionnaire.
Kelly P Arbour-Nicitopoulos, Guy E Faulkner, Tony A Cohn

Schizophr Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Schizophrenia and the incidence of cardiovascular morbidity: a population-based longitudinal study in Ontario, Canada.
Russell C Callaghan, Matthew D Boire, Roberto G Lazo, Kwame McKenzie, Tony Cohn

Schizophr Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychiatric illness and obesity: recognizing the "obesogenic" nature of an inpatient psychiatric setting.
Guy E J Faulkner, Paul F Gorczynski, Tony A Cohn

Psychiatr Serv· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration.
Araba F Chintoh, Steve W Mann, Loretta Lam, Carol Lam, Tony A Cohn

J Clin Psychopharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interventions to reduce weight gain in schizophrenia.
Guy Faulkner, Tony Cohn, Gary Remington

Schizophr Bull· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index, waist circumference and quality of life in individuals with schizophrenia.
Guy Faulkner, Tony Cohn, Gary Remington, Hyacinth Irving

Schizophr Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic monitoring for patients treated with antipsychotic medications.
Tony A Cohn, Michael J Sernyak

Can J Psychiatry· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications.
Guy Faulkner, Tony A Cohn

Can J Psychiatry· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: A preliminary report.
Tony A Cohn, Gary Remington, Robert B Zipursky, Azar Azad, Philip Connolly

Can J Psychiatry· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a physical activity assessment tool for individuals with schizophrenia.
Guy Faulkner, Tony Cohn, Gary Remington

Schizophr Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome.
Tony Cohn, Denis Prud'homme, David Streiner, Homa Kameh, Gary Remington

Can J Psychiatry· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis